Therapy for Diabetes Mellitus and Related Disorders

Cover
Title Page
Copyright Page
Table of Contents
Preface
List of Contributors
Part I: Diagnosis and Classification
	1. Diagnosis
	2. Classification of Diabetes
	3. Role of Diabetes Education in Patient Management
	4. Glucose Monitoring
	5. Medical Nutrition Therapy
	6. Exercise
	7. Epidemiology of Type 1 and Type 2 Diabetes
Part II: Type 1 Diabetes
	8. Type 1 Diabetes: Pathogenesis and Natural History
	9. Assessment and Treatment of Patients with Type 1 Diabetes
	10. Preservation and Prevention Strategies for Type 1 Diabetes
	11. Insulin Pump Therapy: Artificial Pancreas
	12. Psychosocial and Family Issues in Children with Type 1 Diabetes
Part III: Diabetes and Pregnancy
	13. Gestational Diabetes Mellitus: Diagnostic Criteria and Epidemiology
	14. Gestational Diabetes Mellitus: Management
	15. Management of Pregnant Women with Type 1 and Type 2 Diabetes
		Glycemic Control and Pregnancy Outcome
		Preconception Care and Counseling
		Table 15.1 Recommendations for Pregnancy Planning
		Pregnancy Counseling and Late Diabetes Complications
		Maternal Glucose Control During Pregnancy
		Table 15.2 Recommendations during Pregnancy
		Monitoring During Pregnancy
		Nutritional Needs
			Table 15.3 New Recommendations for Total and Rateof Weight Gain During Pregnancy, by PrepregnancyBMI
		Physical Activity During Pregnancy
		Insulin Treatment During Pregnancy
			Risk factors for severe hypoglycemia in T1D include
			Preventive measures to reduce the risk of severehypoglycemia during pregnancy include
			Table 15.4 Practical Approach to the ExpectedAdjustments in Insulin Pump Settings DuringPregnancy. The 2012 Copenhagen Recommendations
				Basal rates:
				Bolus calculator settings:
		Continuous Subcutaneous Insulin Infusion Pump Therapy
		Oral Hypoglycemic Treatment During Pregnancy
		Metformin
Part IV: Type 2 Diabetes
	16. Type 2 Diabetes: Pathogenesis and Natural History
	17. Obesity and Type 2 Diabetes
	18. Obesity and Type 2 Diabetes in Children
	19. Psychosocial Issues Related to Type 2 Diabetes
Part V: Therapeutics of Type 2 Diabetes
	20. Prevention Strategies for Type 2 Diabetes
	21. Metformin
	22. Insulin Secretagogues: Sulfonylureas and Glinides
	23. Future Use of Thiazolidinediones in Type 2 Diabetes: Practical Lessons
	24. Dipeptidyl-Peptidase 4 Inhibitors
	25. Glucagon-Like Peptide-1 Receptor Agonist Therapy for Type 2 Diabetes
	26. α-Glucosidase Inhibitors
	27. Cycloset: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
	28. Sodium-Glucose Cotransporter-2 Inhibitors and Type 2 Diabetes
	29. Insulin Therapy in Type 2 Diabetes
	30. Current and New Long-Acting Insulin Analogs in Development: The Quest for a Better Basal Insulin
	31. Combination Therapy in Type 2 Diabetes
	32. Role of Bariatric Surgery in the Treatment of Type 2 Diabetes
	33. Diabetes in the Elderly
Part VI: Diabetes in the Hospital Setting
	34. Diabetes in Intensive Care Units and Non-ICU Settings
	35. Perioperative Hyperglycemia Management
	36. Post-Transplant Diabetes: Diagnosis, Consequences, and Management
Part VII: Diabetes Complications
	37. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State in Adults
	38. Diabetic Ketoacidosis in Infants, Children, and Adolescents
	39. Glycemic Control and Chronic Diabetes Complications
	40. Hypoglycemia in Diabetes
	41. Ocular Complications
	42. Management of Diabetic Retinopathy
	43. Chronic Kidney Disease Complicating Diabetes
	44. Peripheral Neuropathy in Diabetes
	45. Autonomic Neuropathy in Diabetes
	46. The Diabetic Foot
	47. Macrovascular Complications and Coronary Artery Disease: Primary and Secondary Prevention in Patients with Diabetes
	48. Peripheral Arterial Disease: Diagnosis and Management
	49. Dyslipidemia in Diabetes: Epidemiology, Complications, and Management
	50. Hypertension in Diabetes
	51. Infections and Diabetes
	52. Skin and Subcutaneous Tissues
	53. Hypogonadotropic Hypogonadism in Type 2 Diabetes
	54. Clinical Implications of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
	55. Diabetes and Cancer